Markets:

Overview

News

Currencies

International

Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.490 -0.180 (-10.78%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

35 36 Next >

Why Is Ocugen (OCGN) Stock Up Today? ↗

September 28, 2022

OCGN stock is getting a boost today on news that Ocugen is partnering with Washington University on its Covid-19 vaccine.

Via InvestorPlace

Ocugen Inks US Development Pact For Its Intranasal COVID-19 Vaccine ↗

September 28, 2022

Via Benzinga

So What's Happening With Ocugen Stock Today? ↗

September 28, 2022

Ocugen Inc (NASDAQ: OCGN) shares are trading higher by 3.35% to $1.88 Wednesday morning after the company announced it entered into an exclusive license agreement with Washington University in St.

Via Benzinga

Ocugen Announces Agreement With Washington University in St. Louis for Commercialization of Intranasal COVID-19 Vaccine in U.S., Europe, and Japan

September 28, 2022

From Ocugen

Via GlobeNewswire

Ford, Evotec And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

September 20, 2022

U.S. stock futures traded lower this morning after recording gains in the previous session. Here are some big stocks moving lower in today’s pre-market trading session.

Via Benzinga

Where Ocugen Stands With Analysts ↗

August 23, 2022

Analysts have provided the following ratings for Ocugen (NASDAQ:OCGN) within the last quarter:

Via Benzinga

This COVID-19 Shot Stock Could Have Eye Disease Gene Therapy As Significant Driver, Mizuho Analyst Says ↗

August 23, 2022

Via Benzinga

Ocugen's Partner COVID-19 Vaccine Covaxin Shows Encouraging Action In Children Below 18 Years ↗

June 21, 2022

Via Benzinga

Why O2Micro International Is Trading Higher By 7%; Here Are 25 Stocks Moving Premarket ↗

September 20, 2022

Gainers

Via Benzinga

Why Ocugen Shares Are Diving ↗

September 19, 2022

Ocugen Inc (NASDAQ: OCGN) shares are trading lower by 4.15% to $2.08 Monday morning. Shares of several vaccine companies at large are trading lower possibly after President Biden in a '60 Minutes'...

Via Benzinga

MarketBeat: Week in Review 8/22 - 8/26

August 27, 2022

The markets are selling on news that interest rate hikes will continue past September. But here are some of the other stories for investors to follow this week

Via MarketBeat

Topics Economy

Are Ocugen or Amarin Good Penny Stocks to Buy?

August 24, 2022

This article discusses the current state of Ocugen and Amarin, two penny stocks that highlight the risk and (potential) reward of penny stock investing.

Via MarketBeat

Ocugen Diversifies Its Pipeline With New Cell Therapy Platform ↗

May 24, 2022

Via Benzinga

OCGN Stock Falls Despite Positive FDA Update ↗

May 23, 2022

Shares of the biotech company are falling despite news that the FDA has cleared it to resume clinical trials of its Covid-19 vaccine.

Via InvestorPlace

FDA Removes Clinical Hold On Ocugen's COVID Vaccine Trial ↗

May 23, 2022

Via Benzinga

Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday ↗

September 06, 2022

Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.

Via Benzinga

Indonesia Energy (INDO) Stock Soars as Natural Gas Prices Spike ↗

August 23, 2022

Indonesia Energy (INDO) stock is rising higher on Tuesday alongside the increasing price of natural gas as Europe seeks new fuel sources.

Via InvestorPlace

Why Is Ocugen (OCGN) Stock Climbing Higher Today? ↗

August 23, 2022

Ocugen (OCGN) stock is gaining on Tuesday after Mizuho Securities analysts initiated coverage of the medical company's shares.

Via InvestorPlace

The Top Reasons to Avoid the Ocugen Stock ↗

April 28, 2022

WIth Ocugen, there’s nothing to get excited about here. Avoid the OCGN stock, as it heads significantly lower.

Via InvestorPlace

Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial ↗

April 25, 2022

Via Benzinga

Why Ocugen Shares Are Trading Higher Today ↗

April 18, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2022 ↗

August 23, 2022

Via Benzinga

Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases ↗

August 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Outlook For Ocugen ↗

August 04, 2022

Ocugen (NASDAQ:OCGN) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Ocugen will report an...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 15, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Earnings Scheduled For August 5, 2022 ↗

August 05, 2022

Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.

Via Benzinga

7 Stocks to Short Before July 2022 ↗

June 15, 2022

There are many highly overvalued publicly traded companies that will have trouble staying afloat, giving investors many stocks to short.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2022 ↗

June 02, 2022

Via Benzinga

Novavax Stock Could Give Back More of Its Pandemic-Era Gains ↗

April 22, 2022

While trading at a very low multiple to the low end of earnings estimates, NVAX stock may still be trading at a premium.

Via InvestorPlace

Earnings Scheduled For May 6, 2022 ↗

May 06, 2022

Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion.

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Ocugen, Inc. - Common Stock (NQ:OCGN)

All News about Ocugen, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today